Work

Erlotinib (OSI-774, Tarceva™), a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Combination with Chemotherapy for Advanced Non–Small-Cell Lung Cancer

Year: 2003

Type: article

Source: Clinical Lung Cancer

DOI: 10.1016/s1525-7304(11)70302-3

Authors: Mary Hightower, Chandra P. Belani, Vinay K. Jain

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2079291776

FWCI: 0.567

Cites: 13

Cited by: 14

Related to: 10